Your browser doesn't support javascript.
loading
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
Zhong, Wen-Zhao; Wang, Qun; Mao, Wei-Min; Xu, Song-Tao; Wu, Lin; Wei, Yu-Cheng; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Yin, Rong; Yang, Fan; Ren, Sheng-Xiang; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao; Yang, Jin-Ji; Yan, Hong-Hong; Yang, Xue-Ning; Liu, Si-Yang; Zhou, Qing; Wu, Yi-Long.
Afiliação
  • Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wang Q; Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Mao WM; Zhejiang Cancer Hospital, Hangzhou, China.
  • Xu ST; Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Wu L; Hunan Cancer Hospital, Changsha, China.
  • Wei YC; The Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
  • Liu YY; Shenyang Chest Hospital, Shenyang, China.
  • Chen C; Fujian Medical University Union Hospital, Fuzhou, China.
  • Cheng Y; Jilin Provincial Tumor Hospital, Changchun, China.
  • Yin R; Jiangsu Cancer Hospital, Nanjing, China.
  • Yang F; The People's Hospital of Peking University, Beijing, China.
  • Ren SX; Shanghai Pulmonary Hospital, Shanghai, China.
  • Li XF; Tangdu Hospital, Xi'an, China.
  • Li J; Peking University First Hospital, Beijing, China.
  • Huang C; Fujian Cancer Hospital, Fuzhou, China.
  • Liu ZD; Beijing Chest Hospital, Beijing, China.
  • Xu S; The First Hospital of China Medical University, Shenyang, China.
  • Chen KN; Beijing Cancer Hospital, Beijing, China.
  • Xu SD; Harbin Medical University Cancer Hospital, Harbin, China.
  • Liu LX; West China Hospital of Sichuan University, Chengdu, China.
  • Yu P; Sichuan Cancer Hospital, Chengdu, China.
  • Wang BH; The Northern Jiangsu People's Hospital, Yangzhou, China.
  • Ma HT; The First Affiliated Hospital of Suzhou University, Suzhou, China.
  • Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang XN; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, Guangzhou, China.
J Clin Oncol ; 39(7): 713-722, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33332190
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Gefitinibe / Vinorelbina / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Gefitinibe / Vinorelbina / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China